NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of Alzheimer's disease, Parkinson…
TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (TSXV: MDCX) ("Medicus" or the "Company") is pleased to announce an agreement with Swanielle Inc. (“Swanielle”) to explore expansion of Phase 2 clinical study …
GAITHERSBURG, Md., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Scott Harris, Chief Medical Officer at Altimmune, will present body composition data from the Phase 2 …
Indication covers newborn infants with hypoxic respiratory failure and peri- and post-operative pulmonary hypertension to improve right ventricular function in conjunction with heart surgery A $1 million milestone payment is triggered from Asia-Pacific …
Seralutinib becomes XOMA Royalty’s seventh Phase 3 royalty asset, further building the late-stage pipeline beyond its six current commercial royalty assets Seralutinib is being developed and co-commercialized by Gossamer Bio, Inc., and Chiesi Farmaceutici …
CLEVELAND, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule …
New financing replaces existing credit facility to optimize Company’s capital structure Favorable interest rates and amortization schedules to free up approximately $19 million in cash in 2025 to support business development strategy MONTREAL, Dec. 02, …
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS. VANCOUVER, British Columbia, Dec. 02 …
TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based …
Ce nouveau financement remplace la facilité de crédit existante et vise à optimiser la structure du capital de la Société Les taux d’intérêt et les calendriers d’amortissement favorables devraient libérer environ 19 millions de dollars de trésorerie en …
SOL-1 is the first registrational trial for AXPAXLI™ in wet AMD Topline clinical data from SOL-1 expected in Q4 2025 Active clinical trial sites enrolling patients directly into second registrational trial, SOL-R, while additional sites continue to be …
– Combines Profound’s TULSA-PRO® and Siemens Healthineers’ Magnetom Free.Max – – Supports the Modern Treatment Pathway that allows for more accurate and precise diagnosis, treatment, and follow-up – – Aligns well with CMS 2025 Final Rule establishing …
PDUFA Target Action Date Set for September 26, 2025 SOUTH SAN FRANCISCO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food & Drug Administration (FDA) has accepted the company’s New …
Kellner Group Has Financial Resources AIM Needs Kellner Group Owns 5.04% of Outstanding Shares and is Fully Aligned with Stockholders AIM Cash Conservation Plan is Too Little Too Late, Exposes Desperate Financial Condition AIM Stock Price has Declined 99+% …
Westford USA, Dec. 02, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Debt Collection Software market size will attain a value of USD 2.23 billion by 2031, with a CAGR of 9.10% over the forecast period (2024-2031). Rapidly increasing volume of …
Wilmington, Delaware, Transparency Market Research Inc., Dec. 02, 2024 (GLOBE NEWSWIRE) -- The global medicine cabinets market (医薬品キャビネット市場), valued at $9.4 billion in 2023, is projected to grow at a CAGR of 4.8% from 2024 to 2034, reaching an impressive $ …
NEWARK, Del, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The global power capacitors market is poised for significant growth, driven by increasing demand for energy-efficient solutions, the proliferation of renewable energy, and advancements in technology. Estimated …
MANILA, PHILIPPINES (2 December 2024) — The Asian Development Bank (ADB) has approved a $22.58 million small expenditure financing facility (SEFF) that will support activities to boost project readiness and make project implementation more efficient and …
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elanco Animal Health Incorporated (NYSE:ELAN) and certain of the Company’s senior executives for …
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Chipotle Mexican Grill, Inc. (NYSE: CMG) and certain of the Company’s senior executives for potential …
02 days 20:12:43
